Used as a chiral ligand in asymmetric catalysis, particularly in enantioselective hydrogenation reactions. Its rigid structure and electron-withdrawing trifluoromethyl groups enhance stereocontrol and catalyst efficiency. Commonly employed in the synthesis of pharmaceutical intermediates where high enantiomeric purity is required. Also utilized in transition metal complexes with rhodium or ruthenium for homogeneous catalytic systems. The compound’s stability under various reaction conditions makes it suitable for industrial-scale asymmetric transformations.